Literature DB >> 23696449

The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis.

Nina K Rytwinski1, Michael D Scur, Norah C Feeny, Eric A Youngstrom.   

Abstract

Although co-occurring posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) is associated with greater distress, impairment, and health care utilization than PTSD alone, the magnitude of this problem is uncertain. This meta-analysis aimed to estimate the mean prevalence of current MDD co-occurrence among individuals with PTSD and examine potential moderating variables (U.S. nationality, gender, trauma type, military service, referral type) that may influence the rate of PTSD and MDD co-occurrence. Meta-analytic findings (k = 57 studies; N = 6,670 participants) revealed that 52%, 95% confidence interval [48, 56], of individuals with current PTSD had co-occurring MDD. When outliers were removed, military samples and interpersonal traumas demonstrated higher rates of MDD among individuals with PTSD than civilian samples and natural disasters, respectively. U.S. nationality, gender, and referral type did not significantly account for differences in co-occurrence rates. This high co-occurrence rate accentuates the importance of routinely assessing MDD among individuals with PTSD and continuing research into the association between these disorders.
Copyright © 2013 International Society for Traumatic Stress Studies.

Entities:  

Mesh:

Year:  2013        PMID: 23696449     DOI: 10.1002/jts.21814

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  154 in total

1.  Are PTSD treatment choices and treatment beliefs related to depression symptoms and depression-relevant treatment rationales?

Authors:  Nina K Rytwinski; Cari B Rosoff; Norah C Feeny; Lori A Zoellner
Journal:  Behav Res Ther       Date:  2014-08-01

2.  Socio-demographic patterns of posttraumatic stress disorder in Medellin, Colombia and the context of lifetime trauma exposure.

Authors:  Silvia Lucia Gaviria; Renato D Alarcón; Maria Espinola; Diana Restrepo; Juliana Lotero; Dedsy Y Berbesi; Gloria Maria Sierra; Roberto Chaskel; Zelde Espinel; James M Shultz
Journal:  Disaster Health       Date:  2016-11-22

3.  An Investigation of Depression, Trauma History, and Symptom Severity in Individuals Enrolled in a Treatment Trial for Chronic PTSD.

Authors:  Michele Bedard-Gilligan; Jeanne M Duax Jakob; Lisa Stines Doane; Jeff Jaeger; Afsoon Eftekhari; Norah Feeny; Lori A Zoellner
Journal:  J Clin Psychol       Date:  2015-04-20

4.  Examination of the heterogeneity in PTSD and impulsivity facets: A latent profile analysis.

Authors:  Ateka A Contractor; Stephanie Caldas; Nicole H Weiss; Cherie Armour
Journal:  Pers Individ Dif       Date:  2017-12-20

5.  Anhedonia in Trauma-Exposed Individuals: Functional Connectivity and Decision-Making Correlates.

Authors:  Elizabeth A Olson; Roselinde H Kaiser; Diego A Pizzagalli; Scott L Rauch; Isabelle M Rosso
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-11-16

6.  Post-traumatic stress disorder: what does NICE guidance mean for primary care?

Authors:  Odette Megnin-Viggars; Ifigeneia Mavranezouli; Neil Greenberg; Steve Hajioff; Jonathan Leach
Journal:  Br J Gen Pract       Date:  2019-07       Impact factor: 5.386

7.  PTSD Treatment for Veterans: What's Working, What's New, and What's Next.

Authors:  Miriam Reisman
Journal:  P T       Date:  2016-10

8.  Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: A randomized controlled trial.

Authors:  Edna B Foa; Anu Asnaani; David Rosenfield; Laurie J Zandberg; Peter Gariti; Patricia Imms
Journal:  J Consult Clin Psychol       Date:  2017-06-01

9.  Bioecological Implications of Narrative Exposure Therapy in Low-Resource Settings: Individual, Family, Community, and Socio-Political Contexts.

Authors:  Daniel K Cooper; Elizabeth Wieling; Anett Pfeiffer
Journal:  Aust N Z J Fam Ther       Date:  2019-11-29

Review 10.  Neuroendocrine pathways underlying risk and resilience to PTSD in women.

Authors:  Meghna Ravi; Jennifer S Stevens; Vasiliki Michopoulos
Journal:  Front Neuroendocrinol       Date:  2019-09-19       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.